Telangana's budget for 2025-26 is expected to invigorate Hyderabad's real estate sector with significant allocations for ...

The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...

ASX pharmaceutical companies are retaining their assets longer and advancing them to commercialisation in a bid to maximise ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5%.

Jyotivardhan Jaipuria, Founder & MD, Valentis Advisors, is more optimistic about the market after the correction. He believes ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Bajaj Broking Research recommends Piramal Pharma and PTC India for the upcoming week. Nifty is expected to remain volati ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...